Autoimmune diseases are known for being critical to handle and treat, but today, with the advancements in modern medicines ...

Clinical efficacy was evaluated using the Psoriasis Area and Severity Index (PASI), along with metabolic indicators such as ...

Biologics targeting interleukin (IL)-12, IL-23, and IL-17 may have valuable safety benefits among older adults with psoriatic disease, as a lower rate of serious infection was observed among these ...

A new study in Scientific Reports reveals that skin shame is a key psychological burden for people with atopic dermatitis and ...